As dense breast tissue notification laws expand and draw media coverage, the role of molecular breast imaging (MBI) also is drawing more attention in breast cancer detection. New research looking at everything from lesion detection rates to specificity and dose reductions is helping breast imagers define MBI’s place in the rotation of adjunct breast imaging